RESUMO
Food addiction (FA) is characterized by behavioral and neurochemical changes linked to loss of food intake control. Gut microbiota may influence appetite and food intake via endocrine and neural routes. The gut microbiota is known to impact homeostatic energy mechanisms, but its role in regulating the reward system is less certain. We show that the administration of Bacteroides uniformis CECT 7771 (B. uniformis) in a rat FA model impacts on the brain reward response, ameliorating binge eating and decreasing anxiety-like behavior. These effects are mediated, at least in part, by changes in the levels of dopamine, serotonin, and noradrenaline in the nucleus accumbens and in the expression of dopamine D1 and D2 receptors in the prefrontal cortex and intestine. B. uniformis reverses the fasting-induced microbiota changes and increases the abundance of species linked to healthy metabolotypes. Our data indicate that microbiota-based interventions might help to control compulsive overeating by modulating the reward response.
Assuntos
Ansiedade/metabolismo , Bacteroides/metabolismo , Transtorno da Compulsão Alimentar/metabolismo , Encéfalo/metabolismo , Microbioma Gastrointestinal/fisiologia , Recompensa , Animais , Ansiedade/terapia , Bacteroides/isolamento & purificação , Transtorno da Compulsão Alimentar/terapia , Humanos , Recém-Nascido , Masculino , Microdiálise/métodos , Ratos , Ratos Endogâmicos WKYRESUMO
COVID-19 was first identified in Wuhan, China in December of 2019 and appeared in the United States 1 month later. Between the onset of the pandemic and January 13, 2021, over 92 million people have tested positive for the virus and over 1.9 million people have died globally. Virtually every country in the world has been impacted by this virus. Beginning in March 2020, many U.S. state governments enforced a "quarantine" to respond to the growing health crisis. Citizens were required to remain at home; schools, restaurants, and non-essential businesses were forced to close, and large gatherings were prohibited. Americans' lives were transformed in a span of days as daily routines were interrupted and people were shuttered indoors. Mounting fear and unpredictability coupled with widespread unemployment and social isolation escalated anxiety and impacted the mental health of millions across the globe. Most (53%) U.S. adults reported that the coronavirus outbreak has had a negative impact on their mental health, including inducing or exacerbating use of alcohol, drugs, gambling and overeating as coping mechanisms. In this paper, we will examine substance use and addictive behaviors that have been used to manage the stress and uncertainty wrought by the COVID-19 pandemic. We review the changing treatment landscape as therapy pivoted online and telemedicine became the norm.
RESUMO
Reductions in addiction-like food behaviors and increases in alcohol intake have been reported after weight loss surgery. However, no studies have tracked these measures in combination and prospectively. In this preliminary study, 27 participants underwent bariatric surgery (Roux-en-Y gastric bypass (RYGB) (n = 10) and sleeve gastrectomy (SG) (n = 6)), dietary weight loss (n = 6), or no treatment (n = 5). Participants were weighed, completed the Yale Food Addiction Scale (YFAS), and reported alcohol intake frequency before intervention and at 4 and 24 months after baseline. At 24 months, only the surgery group showed significant reductions in BMI. Between baseline and 24 months, YFAS scores decreased (p = .006) and alcohol intake increased in the surgery group (p = .005). Significant changes were not observed in the diet or no treatment groups.
Assuntos
Consumo de Bebidas Alcoólicas/epidemiologia , Cirurgia Bariátrica , Comportamento Aditivo/epidemiologia , Obesidade Mórbida/epidemiologia , Obesidade Mórbida/cirurgia , Complicações Pós-Operatórias/epidemiologia , Adulto , Cirurgia Bariátrica/métodos , Cirurgia Bariátrica/estatística & dados numéricos , Comportamento Aditivo/complicações , Comportamento Aditivo/cirurgia , Comportamento Alimentar/fisiologia , Feminino , Alimentos , Gastrectomia , Derivação Gástrica , Humanos , Estudos Longitudinais , Masculino , Pessoa de Meia-Idade , Obesidade Mórbida/complicações , Dados Preliminares , Redução de Peso/fisiologiaRESUMO
BACKGROUND: Reward and punishment sensitivities have been identified as potential contributors to binge eating and compensatory behaviors, though few studies have examined gender differences in these behaviors. METHOD: A college-aged sample (N = 1,022) completed both the Eating Disorders Diagnostic Scale (EDDS) and Sensitivity to Punishment/Sensitivity to Reward Questionnaire (SPSRQ). RESULTS: Rates of binge eating were similar in males and females. Among those reporting compensatory behaviors, women reported engaging in compensatory behaviors more frequently than men. Sensitivity to reward and sensitivity to punishment were both positively associated with binge eating frequency in both genders. In contrast, women with high reward sensitivity reported engaging in compensatory behaviors more frequently. CONCLUSIONS: Rates of binge eating and compensatory weight control behaviors were similar between college-aged males and females, though females who engaged in compensatory behaviors did so more frequently than males. Sensitivity to punishment was greater in females, whereas sensitivity to reward was greater in males. Reward and punishment sensitivity were each positively associated with binge eating in both males and females, while only reward sensitivity was positively associated with compensatory behaviors in females.
RESUMO
Both cigarette smoking and obesity are significant public health concerns and are associated with increased risk of early mortality. It is well established that the mesolimbic dopamine pathway is an important component of the reward system within the brain and is implicated in the development of addiction. Indeed, nicotine and highly palatable foods are capable of altering dopamine release within this system, engendering addictive like responses in susceptible individuals. Although additional research is warranted, findings from animal and human literature have elucidated many of neuroadaptions that occur from exposure to nicotine and highly palatable foods, leading to a greater understanding of the underlying mechanisms contributing to these aberrant behaviors. In this review we present the findings taken from preclinical and clinical literature of the known effects of exposure to nicotine and highly palatable foods on the reward related circuitry within the brain. Further, we compare the neurobiological and behavioral overlaps between nicotine, highly palatable foods and obesity. Lastly, we examine the stigma associated with smoking, obesity and food addiction, and the consequences stigma has on the overall health and wellbeing of an individual.
Assuntos
Comportamento Aditivo , Alimentos , Neurobiologia , Nicotina/efeitos adversos , Animais , Encéfalo , Humanos , Obesidade/etiologia , Ratos , RecompensaRESUMO
The alarmingly high rates of overweight and obesity pose a serious global health threat. Numerous factors can result in weight gain, one of which is excess consumption of caloric sweeteners. In an effort to aid weight loss efforts, many people have switched from caloric sweeteners to low calorie sweeteners, which provide sweet taste without the accompanying calories. In this review, we present an overview of the animal literature produced in the last 5years highlighting the effects of sugar consumption on neural pathways involved in energy balance regulation and reward processing. We also examine the latest evidence that is beginning to elucidate the effects of low calorie sweeteners on these neural pathways, as well as how homeostatic and hedonic systems interact in response to, or to influence, sugar consumption.
Assuntos
Homeostase/fisiologia , Adoçantes não Calóricos , Recompensa , Animais , Encéfalo/metabolismo , Humanos , Adoçantes não Calóricos/administração & dosagem , Adoçantes não Calóricos/químicaRESUMO
Binge eating is seen across the spectrum of eating disorder diagnoses as well as among individuals who do not meet diagnostic criteria. Analyses of the specific types of foods that are frequently binged upon reveal that sugar-rich items feature prominently in binge-type meals, making the effects of binge consumption of sugar an important focus of study. One avenue to do this involves the use of animal models. Foundational and recent studies of animal models of sugar bingeing, both outlined here, lend insight into the various neurotransmitters and neuropeptides that may participate in or be altered by this behavior. Further, several preclinical studies incorporating sugar bingeing paradigms have explored the utility of pharmacological agents that target such neural systems for reducing sugar bingeing in an effort to enhance clinical treatment. Indeed, the translational implications of findings generated using animal models of sugar bingeing are considered here, along with potential avenues for further study.
Assuntos
Transtorno da Compulsão Alimentar , Modelos Animais de Doenças , Comportamento Alimentar , Animais , Carboidratos , Humanos , Camundongos , Ratos , Pesquisa Translacional BiomédicaRESUMO
OBJECTIVES: We propose that highly processed foods share pharmacokinetic properties (e.g. concentrated dose, rapid rate of absorption) with drugs of abuse, due to the addition of fat and/or refined carbohydrates and the rapid rate the refined carbohydrates are absorbed into the system, indicated by glycemic load (GL). The current study provides preliminary evidence for the foods and food attributes implicated in addictive-like eating. DESIGN: Cross-sectional. SETTING: University (Study One) and community (Study Two). PARTICIPANTS: 120 undergraduates participated in Study One and 384 participants recruited through Amazon MTurk participated in Study Two. MEASUREMENTS: In Study One, participants (n = 120) completed the Yale Food Addiction Scale (YFAS) followed by a forced-choice task to indicate which foods, out of 35 foods varying in nutritional composition, were most associated with addictive-like eating behaviors. Using the same 35 foods, Study Two utilized hierarchical linear modeling to investigate which food attributes (e.g., fat grams) were related to addictive-like eating behavior (at level one) and explored the influence of individual differences for this association (at level two). RESULTS: In Study One, processed foods, higher in fat and GL, were most frequently associated with addictive-like eating behaviors. In Study Two, processing was a large, positive predictor for whether a food was associated with problematic, addictive-like eating behaviors. BMI and YFAS symptom count were small-to-moderate, positive predictors for this association. In a separate model, fat and GL were large, positive predictors of problematic food ratings. YFAS symptom count was a small, positive predictor of the relationship between GL and food ratings. CONCLUSION: The current study provides preliminary evidence that not all foods are equally implicated in addictive-like eating behavior, and highly processed foods, which may share characteristics with drugs of abuse (e.g. high dose, rapid rate of absorption) appear to be particularly associated with "food addiction."
Assuntos
Comportamento Aditivo , Gorduras na Dieta/análise , Comportamento Alimentar/psicologia , Manipulação de Alimentos , Alimentos , Índice Glicêmico , Adolescente , Comportamento Aditivo/etiologia , Índice de Massa Corporal , Feminino , Humanos , Masculino , Fatores Sexuais , Inquéritos e Questionários , Adulto JovemRESUMO
The brain responds to macronutrients via intricate mechanisms. We review how the brain's neural systems implicated in homeostatic control of feeding and hedonic responses are influenced by the ingestion of specific types of food. We discuss how these neural systems are dysregulated in preclinical models of obesity. Findings from these studies can increase our understanding of overeating and, perhaps in some cases, the development of obesity. In addition, a greater understanding of the neural circuits affected by the consumption of specific macronutrients, and by obesity, might lead to new treatments and strategies for preventing unhealthy weight gain.
Assuntos
Regulação do Apetite , Encéfalo/fisiopatologia , Dieta , Ingestão de Alimentos , Comportamento Alimentar , Trato Gastrointestinal/inervação , Obesidade/fisiopatologia , Filosofia , Animais , Encéfalo/metabolismo , Dieta/efeitos adversos , Dieta Hiperlipídica/efeitos adversos , Carboidratos da Dieta/efeitos adversos , Carboidratos da Dieta/metabolismo , Gorduras na Dieta/efeitos adversos , Gorduras na Dieta/metabolismo , Proteínas Alimentares/efeitos adversos , Proteínas Alimentares/metabolismo , Sistema Nervoso Entérico/fisiopatologia , Trato Gastrointestinal/metabolismo , Homeostase , Humanos , Vias Neurais/fisiopatologia , Obesidade/metabolismo , Obesidade/psicologiaRESUMO
Obesity among the elderly is a growing public health concern. Among the various factors that may contribute to the current rates of obesity is the rewarding aspect of highly palatable foods and beverages, which may lead to overconsumption and excess caloric intake. The present review describes recent research supporting the hypothesis that, for some individuals, the consumption these highly palatable foods and beverages may lead to the development of addictive-like behaviors. In particular, the authors consider the relevance of this hypothesis to the ageing population.
Assuntos
Envelhecimento , Comportamento Aditivo , Comportamento Alimentar , Obesidade , Idoso , Envelhecimento/fisiologia , Envelhecimento/psicologia , Comportamento Aditivo/complicações , Comportamento Aditivo/fisiopatologia , Ingestão de Energia , Comportamento Alimentar/fisiologia , Comportamento Alimentar/psicologia , Humanos , Obesidade/etiologia , Obesidade/prevenção & controle , Obesidade/psicologiaRESUMO
This article summarizes presentations from "Neurocognition: The FoodBrain Connection" symposium held at the ASN Scientific Sessions and Annual Meeting at Experimental Biology 2014 in San Diego, CA on 28 April 2014. Presenters reviewed research from several disciplines, including neurobiology, neuropsychology, cognitive neuroscience, and nutrition, concerning the role of the brain in food-intake regulation, reward, and addiction. A transdisciplinary approach was taken to evaluate the state of the science regarding addiction models, as well as research gaps and future research necessary to understand neurocircuitry and pathways involved in food-intake control and behavior in humans.
Assuntos
Encéfalo/metabolismo , Cognição/fisiologia , Ingestão de Energia/fisiologia , Neurônios/metabolismo , Regulação do Apetite/fisiologia , Congressos como Assunto , Alimentos , HumanosRESUMO
Excess consumption of palatable food has been shown to affect reward-related brain regions, and pharmaceutical treatments for drug addiction may also be effective in treating overeating of such foods. The GABA-B agonist baclofen and opioid antagonist naltrexone have both been used to treat addiction, and have been shown to suppress intake of certain foods. The combination of these drugs has shown to be more effective in reducing alcohol consumption than either drug alone. The present study assessed the effects of naltrexone and baclofen, alone and in combination, on intake of foods comprised of various macronutrients. Male Sprague-Dawley rats were given 12-hr daily access to chow and a fat emulsion, sugar-fat emulsion, or a sugar solution for 21 days. Rats were then administered (intraperitoneal) baclofen-naltrexone combinations (0.1 mg/kg naltrexone and 1.0 mg/kg baclofen, 1.0 mg/kg naltrexone and 1.8 mg/kg baclofen), and naltrexone (0.1, 1.0 mg/kg) and baclofen (1.0, 1.8 mg/kg) alone. The high dose of the baclofen-naltrexone combination reduced palatable food intake in both the fat and sugar-fat groups compared with vehicle, without affecting chow consumption in these groups. Naltrexone showed little significant effects on intake of either palatable food or chow. Baclofen also reduced palatable food intake in the fat and fat-sugar groups, but differences were only noted between the low and high dose. The combination of baclofen and naltrexone may be a useful tool in selectively targeting the consumption of high-fat and sugar- and fat-rich foods.
Assuntos
Baclofeno/farmacologia , Ingestão de Alimentos/efeitos dos fármacos , Preferências Alimentares/efeitos dos fármacos , Agonistas dos Receptores de GABA-B/farmacologia , Naltrexona/farmacologia , Antagonistas de Entorpecentes/farmacologia , Análise de Variância , Animais , Relação Dose-Resposta a Droga , Combinação de Medicamentos , Comportamento Alimentar/efeitos dos fármacos , Masculino , Ratos , Ratos Sprague-DawleyRESUMO
With rising rates of obesity, research continues to explore the contributions of homeostatic and hedonic mechanisms related to eating behaviour. In this Review, we synthesize the existing information on select biological mechanisms associated with reward-related food intake, dealing primarily with consumption of highly palatable foods. In addition to their established functions in normal feeding, three primary peripheral hormones (leptin, ghrelin and insulin) play important parts in food reward. Studies in laboratory animals and humans also show relationships between hyperphagia or obesity and neural pathways involved in reward. These findings have prompted questions regarding the possibility of addictive-like aspects in food consumption. Further exploration of this topic may help to explain aberrant eating patterns, such as binge eating, and provide insight into the current rates of overweight and obesity.
Assuntos
Ingestão de Alimentos , Obesidade/etiologia , Recompensa , Adulto , Animais , Comportamento Aditivo , Encéfalo/efeitos dos fármacos , Encéfalo/fisiologia , Bulimia/fisiopatologia , Dopamina/fisiologia , Comportamento Alimentar/efeitos dos fármacos , Feminino , Grelina/fisiologia , Homeostase , Humanos , Insulina/fisiologia , Leptina/fisiologia , Masculino , Obesidade/metabolismo , Receptores Dopaminérgicos/fisiologia , Aumento de PesoRESUMO
Cessation of drug use often coincides with increased food consumption and weight gain in recovering addicts. However, it is not known whether this phenomenon (particularly the weight gain) is uniquely human, or whether it represents a consequence of drug cessation common across species. To address this issue, rats (n = 10/group) were given systemic injections of D-amphetamine (3 mg/kg) or an equal volume of saline vehicle for 9 consecutive days. Beginning 2 days after the final injection, rats were given free access to a highly palatable food mixture (consisting of sugar and butter) along with their standard chow diet, and food consumption and body weight were measured every 48 h for 30 days. Consistent with clinical observations, amphetamine-treated rats showed a greater increase in body weight over the course of the 30 days relative to vehicle-treated rats. Surprisingly, there was no difference in highly palatable food consumption between amphetamine- and vehicle-treated groups, but the amphetamine-treated group consumed significantly more standard chow than the control group. The finding that a history of chronic amphetamine exposure increases food consumption is consistent with previous work in humans showing that withdrawal from drugs of abuse is associated with overeating and weight gain. The current findings may reflect amphetamine-induced sensitization of mechanisms involved in reward motivation, suggesting that weight gain following drug cessation in humans could be due to similar mechanisms.
Assuntos
Anfetamina/farmacologia , Ingestão de Alimentos , Ingestão de Energia , Comportamento Alimentar , Aumento de Peso , Anfetamina/administração & dosagem , Animais , Comportamento Animal , Dieta , Ingestão de Alimentos/psicologia , Preferências Alimentares , Masculino , Motivação , Ratos Long-Evans , Recompensa , PaladarRESUMO
Binge eating palatable foods has been shown to have behavioral and neurochemical similarities to drug addiction. GS 455534 is a highly selective reversible aldehyde dehydrogenase 2 inhibitor that has been shown to reduce alcohol and cocaine intake in rats. Given the overlaps between binge eating and drug abuse, we examined the effects of GS 455534 on binge eating and subsequent dopamine release. Sprague-Dawley rats were maintained on a sugar (experiment 1) or fat (experiment 2) binge eating diet. After 25 days, GS 455534 was administered at 7.5 and 15 mg/kg by an intraperitoneal injection, and food intake was monitored. In experiment 3, rats with cannulae aimed at the nucleus accumbens shell were maintained on the binge sugar diet for 25 days. Microdialysis was performed, during which GS 455534 15 mg/kg was administered, and sugar was available. Dialysate samples were analyzed to determine extracellular levels of dopamine. In experiment 1, GS 455534 selectively decreased sugar intake food was made available in the Binge Sugar group but not the Ad libitum Sugar group, with no effect on chow intake. In experiment 2, GS 455534 decreased fat intake in the Binge Fat group, but not the Ad libitum Fat group, however, it also reduced chow intake. In experiment 3, GS 455534 attenuated accumbens dopamine release by almost 50% in binge eating rats compared with the vehicle injection. The findings suggest that selective reversible aldehyde dehydrogenase 2 inhibitors may have the therapeutic potential to reduce binge eating of palatable foods in clinical populations.
Assuntos
Bulimia/tratamento farmacológico , Dopamina/metabolismo , Inibidores Enzimáticos/farmacologia , Isoflavonas/farmacologia , Núcleo Accumbens/efeitos dos fármacos , Núcleo Accumbens/metabolismo , Aldeído Desidrogenase/antagonistas & inibidores , Aldeído-Desidrogenase Mitocondrial , Animais , Regulação do Apetite/efeitos dos fármacos , Regulação do Apetite/fisiologia , Peso Corporal/efeitos dos fármacos , Bulimia/metabolismo , Gorduras na Dieta , Sacarose Alimentar , Relação Dose-Resposta a Droga , Ingestão de Alimentos/efeitos dos fármacos , Masculino , Proteínas Mitocondriais/antagonistas & inibidores , Ratos , Ratos Sprague-DawleyRESUMO
OBJECTIVE: Hyperphagia is a central feature of inherited disorders (e.g., Prader-Willi Syndrome) in which obesity is a primary phenotypic component. Hyperphagia may also contribute to obesity as observed in the general population, thus raising the potential importance of common underlying mechanisms and treatments. Substantial gaps in understanding the molecular basis of inherited hyperphagia syndromes are present as are a lack of mechanistic of mechanistic targets that can serve as a basis for pharmacologic and behavioral treatments. DESIGN AND METHODS: International conference with 28 experts, including scientists and caregivers, providing presentations, panel discussions, and debates. RESULTS: The reviewed collective research and clinical experience provides a critical body of new and novel information on hyperphagia at levels ranging from molecular to population. Gaps in understanding and tools needed for additional research were identified. CONCLUSIONS: This report documents the full scope of important topics reviewed at a comprehensive international meeting devoted to the topic of hyperphagia and identifies key areas for future funding and research.